Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17253023 | MRI STREAK-ARTIFACT SUPPRESSION, SYSTEM AND METHOD | December 2020 | May 2024 | Allow | 41 | 1 | 0 | Yes | No |
| 17100062 | REDUCTION OF BIAS IN GENOMIC COVERAGE MEASUREMENTS | November 2020 | May 2023 | Allow | 30 | 1 | 0 | No | No |
| 17073074 | METHODS AND SYSTEMS FOR GENERATION AND ERROR-CORRECTION OF UNIQUE MOLECULAR INDEX SETS WITH HETEROGENEOUS MOLECULAR LENGTHS | October 2020 | April 2023 | Allow | 30 | 1 | 0 | No | No |
| 17039106 | NUCLEIC ACID AMPLIFICATION AND DETECTION DEVICES, SYSTEMS AND METHODS | September 2020 | October 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 16978286 | METHOD AND APPARATUS FOR MONITORING A HUMAN OR ANIMAL SUBJECT | September 2020 | July 2024 | Abandon | 46 | 1 | 0 | No | No |
| 16937464 | SIGNAL ENCODING AND DECODING IN MULTIPLEXED BIOCHEMICAL ASSAYS | July 2020 | August 2023 | Allow | 37 | 2 | 0 | Yes | No |
| 16936885 | SIMULATION OF THE DEPLOYMENT OF AN ENDOPROSTHESIS IN REAL TIME | July 2020 | April 2024 | Allow | 45 | 1 | 0 | No | No |
| 16934994 | SYSTEMS AND METHODS FOR IDENTIFYING STRUCTURAL VARIANTS | July 2020 | March 2024 | Allow | 44 | 1 | 0 | Yes | No |
| 16927533 | DENSITY-FUNCTIONAL THEORY DETERMINATIONS USING A QUANTUM COMPUTING SYSTEM | July 2020 | January 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 16960830 | PEELING TYPE LASER TOOTH PREPARING METHOD, APPARATUS AND DEVICE, AND MEDIUM | July 2020 | March 2024 | Allow | 44 | 1 | 0 | Yes | No |
| 16921303 | DISTRIBUTED DATA ANALYTICS | July 2020 | July 2023 | Allow | 36 | 1 | 0 | Yes | No |
| 16912877 | METHOD FOR IMPROVING VEGF-RECEPTOR BLOCKING SELECTIVITY OF AN ANTI-VEGF ANTIBODY | June 2020 | July 2024 | Abandon | 49 | 2 | 1 | No | No |
| 15929565 | MODELS FOR ANALYZING DATA FROM SEQUENCING-BY-SYNTHESIS OPERATIONS | May 2020 | January 2023 | Allow | 32 | 1 | 0 | No | No |
| 16866922 | PERSONALIZED COSMETIC SYSTEM | May 2020 | January 2023 | Allow | 33 | 1 | 1 | Yes | No |
| 16866221 | ENGINEERED MICROPARTICLES FOR MACROMOLECULE DELIVERY | May 2020 | January 2023 | Allow | 33 | 1 | 1 | No | No |
| 16864744 | SIGNAL ENCODING AND DECODING IN MULTIPLEXED BIOCHEMICAL ASSAYS | May 2020 | August 2023 | Allow | 39 | 2 | 0 | Yes | No |
| 16846346 | Method and apparatus for facilitating the binding of biological macromolecules with the use of gluing molecular agents with applications in RAS mutations and related conditions | April 2020 | December 2022 | Abandon | 32 | 1 | 0 | No | No |
| 16831747 | SCAFFOLD-ORIENTED UNIVERSAL LINE SYSTEM | March 2020 | April 2024 | Allow | 49 | 1 | 1 | No | No |
| 16813136 | NMR Quantification of TMAO | March 2020 | June 2023 | Allow | 39 | 2 | 0 | Yes | No |
| 16801588 | Quantum Mechanical/X-ray Crystallography Diagnostic for Proteins | February 2020 | February 2023 | Allow | 35 | 1 | 0 | Yes | No |
| 16777597 | METHOD, PROCESSOR DEVICE AND COMPUTER PROGRAM PRODUCT FOR DESIGNING INTERVENTION INTO THE BEHAVIOUR OF A REAL COMPLEX SYSTEM | January 2020 | February 2024 | Allow | 48 | 0 | 1 | Yes | No |
| 16775233 | METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS | January 2020 | April 2023 | Abandon | 39 | 1 | 0 | No | No |
| 16740989 | APPARATUS AND METHOD FOR ESTIMATING ANALYTE CONCENTRATION | January 2020 | October 2023 | Allow | 45 | 2 | 0 | Yes | No |
| 16723086 | QUANTUM COMPUTING THERMODYNAMIC OBSERVABLES OF A CHEMICAL SYSTEM | December 2019 | April 2023 | Allow | 40 | 3 | 0 | Yes | No |
| 16692085 | Composition Tracking of Mixed Species in Chemical Processes | November 2019 | June 2023 | Allow | 43 | 1 | 0 | Yes | No |
| 16680468 | METHOD AND APPARATUS FOR ANALYTE MEASUREMENTS USING CALIBRATION SETS | November 2019 | April 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16673104 | Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements | November 2019 | November 2023 | Allow | 48 | 2 | 0 | Yes | No |
| 16663243 | SYSTEMS AND METHODS FOR ADAPTIVE LOCAL ALIGNMENT FOR GRAPH GENOMES | October 2019 | June 2023 | Allow | 43 | 2 | 0 | No | No |
| 16660059 | PRECISION-PRESERVING QUBIT REDUCTION BASED ON SPATIAL SYMMETRIES IN FERMIONIC SYSTEMS | October 2019 | October 2023 | Allow | 48 | 2 | 0 | Yes | No |
| 16605298 | METHODS FOR PREPARING OPTIMAL COMBINATION OF OLIGONUCLEOTIDES | October 2019 | February 2024 | Allow | 52 | 1 | 1 | No | No |
| 16601350 | SYSTEMS AND METHODS FOR SIMULATION-BASED RADIATION ESTIMATION AND PROTECTION FOR MEDICAL PROCEDURES | October 2019 | January 2023 | Abandon | 39 | 1 | 0 | No | No |
| 16595758 | RATIONAL DRUG DESIGN WITH COMPUTATIONAL FREE ENERGY DIFFERENCE CALCULATION USING A MODIFIED BOND STRETCH POTENTIAL | October 2019 | September 2022 | Allow | 35 | 1 | 0 | No | No |
| 16549684 | METHODS FOR NUCLEIC ACID SIZE DETECTION OF REPEAT SEQUENCES | August 2019 | October 2023 | Allow | 50 | 2 | 0 | No | No |
| 16529760 | METHOD AND SYSTEM FOR ANATOMICAL TREE STRUCTURE ANALYSIS | August 2019 | July 2022 | Allow | 36 | 1 | 0 | No | No |
| 16525822 | SYSTEMS AND METHODS FOR ANALYZING CIRCULATING TUMOR DNA | July 2019 | August 2022 | Allow | 37 | 1 | 0 | No | No |
| 16506388 | CHD Risk Stratification Evaluations for Subjects With High Levels of Large HDL-P | July 2019 | March 2023 | Allow | 44 | 2 | 0 | Yes | No |
| 16506287 | METHODS, SYSTEMS AND PROCESSES OF IDENTIFYING GENETIC VARIATION IN HIGHLY SIMILAR GENES | July 2019 | November 2022 | Allow | 41 | 1 | 1 | No | No |
| 16460269 | Multi-Parameter Diabetes Risk Evaluations | July 2019 | March 2023 | Allow | 44 | 2 | 0 | Yes | No |
| 16445712 | SYSTEM AND METHOD FOR HARMONIC MODULATION OF STANDING WAVEFIELDS FOR SPATIAL FOCUSING, MANIPULATION, AND PATTERNING | June 2019 | March 2023 | Allow | 45 | 1 | 0 | Yes | No |
| 16441690 | ENCODING DATA FROM GENETIC TRAITS RELEVANT TO ILLNESS DIAGNOSIS AND HERITAGE | June 2019 | February 2023 | Allow | 44 | 2 | 0 | Yes | No |
| 16470140 | CLASSIFICATION ANALYSIS METHOD, CLASSIFICATION ANALYSIS DEVICE, AND STORAGE MEDIUM FOR CLASSIFICATION ANALYSIS | June 2019 | February 2023 | Abandon | 44 | 2 | 0 | No | No |
| 16435406 | SCAR-LESS MULTI-PART DNA ASSEMBLY DESIGN AUTOMATION | June 2019 | April 2023 | Allow | 46 | 1 | 0 | No | No |
| 16434677 | SYSTEMS AND METHODS FOR IDENTIFYING SEQUENCE VARIATION ASSOCIATED WITH GENETIC DISEASES | June 2019 | April 2023 | Allow | 46 | 2 | 0 | Yes | No |
| 16405050 | IDENTIFICATION USING SPECTROSCOPY | May 2019 | February 2023 | Allow | 45 | 3 | 0 | Yes | No |
| 16397281 | SYSTEM AND METHOD FOR MOLECULAR DESIGN ON A QUANTUM COMPUTER | April 2019 | March 2023 | Allow | 47 | 2 | 0 | No | No |
| 16380489 | INTENSITY NORMALIZATION IN IMAGING MASS SPECTROMETRY | April 2019 | June 2023 | Allow | 50 | 3 | 0 | Yes | No |
| 16377680 | BIOLOGICAL INFORMATION PROCESSING METHOD AND DEVICE, RECORDING MEDIUM AND PROGRAM | April 2019 | March 2023 | Allow | 47 | 4 | 1 | Yes | No |
| 16089593 | SCREENING METHOD FOR CANDIDATE SUBSTANCES FOR ACTIVE COMPONENT TO PREVENT OR TREAT AT LEAST ONE DISEASE SELECTED FROM THE GROUP CONSISTING OF RENAL HYPOFUNCTION, CHRONIC KIDNEY DISEASE AND KIDNEY FAILURE | March 2019 | October 2023 | Allow | 60 | 1 | 1 | No | No |
| 16355886 | METHOD FOR MEASURING A BIOLOGICAL VALUE OF A LIVER | March 2019 | November 2022 | Abandon | 44 | 0 | 1 | No | No |
| 16284470 | INTERACTIVE-AWARE CLUSTERING OF STABLE STATES | February 2019 | August 2022 | Allow | 42 | 3 | 0 | Yes | No |
| 16269092 | METHOD AND APPARATUS FOR GENERATING CHEMICAL STRUCTURE USING NEURAL NETWORK | February 2019 | January 2023 | Allow | 48 | 1 | 1 | Yes | No |
| 16258299 | MACHINE LEARNING ENABLED PULSE AND BASE CALLING FOR SEQUENCING DEVICES | January 2019 | August 2022 | Allow | 43 | 1 | 0 | No | No |
| 16249803 | Discovering Population Structure From Patterns of Identity-By-Descent | January 2019 | August 2022 | Allow | 43 | 1 | 0 | Yes | No |
| 16245306 | ANALYSIS OF MEASUREMENTS OF A POLYMER | January 2019 | December 2023 | Allow | 59 | 5 | 0 | Yes | No |
| 16226575 | SYSTEMS AND METHODS FOR DE NOVO PEPTIDE SEQUENCING FROM DATA-INDEPENDENT ACQUISITION USING DEEP LEARNING | December 2018 | February 2023 | Allow | 50 | 1 | 1 | No | No |
| 16191069 | METHOD FOR ANALYZING SULFIDE-BASED SOLID ELECTROLYTE USING COMPUTER SIMULATION AND PROGRAM FOR ANALYZING SULFIDE-BASED SOLID ELECTROLYTE USING COMPUTER SIMULATION | November 2018 | November 2022 | Allow | 48 | 1 | 1 | No | No |
| 16179280 | METHODS AND SYSTEMS FOR PRODUCING AN EXPANDED TRAINING SET FOR MACHINE LEARNING USING BIOLOGICAL SEQUENCES | November 2018 | May 2023 | Allow | 54 | 2 | 0 | No | No |
| 16097897 | METHODS FOR IDENTIFYING TREATMENT TARGETS BASED ON MULTIOMICS DATA | October 2018 | January 2023 | Allow | 50 | 1 | 1 | No | No |
| 16172289 | METHODS FOR IDENTIFYING INHIBITORS OF AMYLOID PROTEIN AGGREGATION | October 2018 | September 2022 | Allow | 47 | 1 | 1 | No | No |
| 16081102 | IN SILICO PROCESS FOR SELECTING PROTEIN FORMULATION EXCIPIENTS | August 2018 | July 2022 | Allow | 47 | 2 | 0 | No | No |
| 16053679 | GRAPH NEURAL NETWORKS FOR REPRESENTING MICROORGANISMS | August 2018 | October 2022 | Abandon | 50 | 1 | 0 | No | No |
| 16037949 | METHODS AND SYSTEMS FOR DE NOVO PEPTIDE SEQUENCING USING DEEP LEARNING | July 2018 | November 2022 | Allow | 52 | 3 | 1 | Yes | No |
| 16035470 | SYSTEMS AND METHODS FOR MULTIPLEX PCR PRIMER SELECTION | July 2018 | July 2022 | Allow | 48 | 1 | 1 | No | No |
| 15780673 | METHODS AND SYSTEMS FOR DETERMINATION OF THE NUMBER OF CONTRIBUTORS TO A DNA MIXTURE | June 2018 | April 2024 | Allow | 60 | 2 | 0 | No | No |
| 15984129 | COMPUTATIONAL METHOD FOR CLASSIFYING AND PREDICTING LIGAND DOCKING CONFORMATIONS | May 2018 | July 2022 | Allow | 50 | 1 | 1 | No | No |
| 15957883 | USES OF SYSTEMS WITH DEGREES OF FREEDOM POISED BETWEEN FULLY QUANTUM AND FULLY CLASSICAL STATES | April 2018 | March 2023 | Abandon | 59 | 2 | 1 | No | No |
| 15947255 | MEASUREMENT METHOD, MEASURING APPARATUS, PROGRAM, AND METHOD FOR OBTAINING AND DISPLAYING QUALITATIVE DETERMINATION RESULT | April 2018 | July 2022 | Allow | 51 | 2 | 0 | Yes | No |
| 15918369 | COMPENSATION FOR SPECTRAL CROSSTALK IN MULTIPLEX NUCLEIC ACID AMPLIFICATION | March 2018 | October 2022 | Allow | 55 | 3 | 0 | Yes | No |
| 15899866 | Predictive Test for Prognosis of Myelodysplastic Syndrome Patients Using Mass Spectrometry of Blood-Based Sample | February 2018 | October 2022 | Allow | 56 | 4 | 0 | Yes | No |
| 15579363 | A Method Of Assessing Protein Modification Status And Identifying Biomarkers Linked To Cell Signaling Pathways | December 2017 | November 2023 | Abandon | 60 | 4 | 1 | No | No |
| 15440269 | Systems and Methods for Collecting and Transmitting Assay Results | February 2017 | July 2024 | Abandon | 60 | 5 | 1 | No | Yes |
| 15433396 | COMPOSITIONS AND METHODS FOR PROTEIN PRODUCTION | February 2017 | August 2022 | Allow | 60 | 5 | 1 | No | No |
| 15040729 | SYSTEMS AND METHODS FOR IMAGING CHANGES IN TISSUE | February 2016 | October 2022 | Abandon | 60 | 6 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner NEGIN, RUSSELL SCOTT.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner NEGIN, RUSSELL SCOTT works in Art Unit 1672 and has examined 73 patent applications in our dataset. With an allowance rate of 82.2%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 45 months.
Examiner NEGIN, RUSSELL SCOTT's allowance rate of 82.2% places them in the 56% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by NEGIN, RUSSELL SCOTT receive 1.78 office actions before reaching final disposition. This places the examiner in the 36% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by NEGIN, RUSSELL SCOTT is 45 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +27.8% benefit to allowance rate for applications examined by NEGIN, RUSSELL SCOTT. This interview benefit is in the 74% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 24.3% of applications are subsequently allowed. This success rate is in the 38% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 76.2% of cases where such amendments are filed. This entry rate is in the 95% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants file petitions regarding this examiner's actions, 111.1% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.